id	sid	eid	entity	type
bptjm-32	1	1	berkeley pharma tech journal	ORG
bptjm-32	2	1	august 28	DATE
bptjm-32	2	2	2022	CARDINAL
bptjm-32	2	3	september 26	DATE
bptjm-32	2	4	2022	CARDINAL
bptjm-32	2	5	december 28	DATE
bptjm-32	2	6	2022	CARDINAL
bptjm-32	2	7	4.0	CARDINAL
bptjm-32	5	1	5-ht	QUANTITY
bptjm-32	6	1	5-ht	QUANTITY
bptjm-32	11	1	magda wojtara	PERSON
bptjm-32	11	2	berkeley pharma tech journal	ORG
bptjm-32	11	3	105 1	CARDINAL
bptjm-32	12	1	relationship1	PERSON
bptjm-32	13	1	manifestation2	PERSON
bptjm-32	14	1	the past decade	DATE
bptjm-32	17	1	1	CARDINAL
bptjm-32	17	2	three	CARDINAL
bptjm-32	18	1	system3	PERSON
bptjm-32	20	1	5-ht	QUANTITY
bptjm-32	20	2	brain4	PERSON
bptjm-32	21	1	berkeley pharma tech journal	ORG
bptjm-32	21	2	106	CARDINAL
bptjm-32	21	3	1	CARDINAL
bptjm-32	21	4	three	CARDINAL
bptjm-32	24	1	flow5	ORG
bptjm-32	25	1	stress5	PERSON
bptjm-32	25	2	brain5	EVENT
bptjm-32	27	1	treatments6	PERSON
bptjm-32	28	1	strategy7	LOC
bptjm-32	29	1	the 1950s	DATE
bptjm-32	31	1	berkeley pharma tech journal	ORG
bptjm-32	31	2	107	CARDINAL
bptjm-32	33	1	potential1	PERSON
bptjm-32	34	1	responses1	PERSON
bptjm-32	35	1	aging8	GPE
bptjm-32	36	1	aging8,9	PERSON
bptjm-32	38	1	process9	PRODUCT
bptjm-32	39	1	2	CARDINAL
bptjm-32	39	2	daily	DATE
bptjm-32	46	1	berkeley pharma tech journal	ORG
bptjm-32	46	2	108	CARDINAL
bptjm-32	46	3	2	CARDINAL
bptjm-32	51	1	microbes10	ORG
bptjm-32	53	1	2	CARDINAL
bptjm-32	58	1	acth	PERSON
bptjm-32	59	1	pomc	PERSON
bptjm-32	60	1	berkeley pharma tech journal	ORG
bptjm-32	60	2	109	CARDINAL
bptjm-32	62	1	crf	LOC
bptjm-32	63	1	crf1	PRODUCT
bptjm-32	64	1	crf1	ORG
bptjm-32	72	1	5-ht	QUANTITY
bptjm-32	75	1	three	CARDINAL
bptjm-32	75	2	uvc	ORG
bptjm-32	75	3	200-280	CARDINAL
bptjm-32	75	4	280-320	CARDINAL
bptjm-32	75	5	uva	PRODUCT
bptjm-32	75	6	320	CARDINAL
bptjm-32	76	1	uvc	ORG
bptjm-32	77	1	energy14	GPE
bptjm-32	78	1	uva	FAC
bptjm-32	78	2	berkeley pharma tech journal	ORG
bptjm-32	79	1	110	CARDINAL
bptjm-32	80	1	5-ht receptor14	QUANTITY
bptjm-32	82	1	3	CARDINAL
bptjm-32	82	2	skin15	ORG
bptjm-32	85	1	6 months	DATE
bptjm-32	86	1	drugs18	ORG
bptjm-32	87	1	4	CARDINAL
bptjm-32	88	1	barrier16	ORG
bptjm-32	89	1	92%	PERCENT
bptjm-32	89	2	vla-4 positive16	ORG
bptjm-32	90	1	1	CARDINAL
bptjm-32	91	1	melanoma19	PERSON
bptjm-32	93	1	pmel17	ORG
bptjm-32	93	2	19	CARDINAL
bptjm-32	94	1	pd19	ORG
bptjm-32	95	1	berkeley pharma tech journal	ORG
bptjm-32	95	2	111 4	DATE
bptjm-32	95	3	antipsoriatic drug	ORG
bptjm-32	95	4	factors15	ORG
bptjm-32	96	1	5-ht	QUANTITY
bptjm-32	97	1	th1	ORG
bptjm-32	97	2	th17 profiles20	NORP
bptjm-32	98	1	stress15	GPE
bptjm-32	99	1	first	ORDINAL
bptjm-32	100	1	psoriasis20	NORP
bptjm-32	103	1	psoriasis20	NORP
bptjm-32	105	1	depression20	ORG
bptjm-32	108	1	approaches21	ORG
bptjm-32	109	1	th17	PRODUCT
bptjm-32	109	2	psoriasis21	ORG
bptjm-32	110	1	berkeley pharma tech journal	ORG
bptjm-32	110	2	112 5	DATE
bptjm-32	110	3	the past decade	DATE
bptjm-32	111	1	manifestation1	PERSON
bptjm-32	115	1	trauma23	GPE
bptjm-32	116	1	5-ht receptors24	QUANTITY
bptjm-32	117	1	berkeley pharma tech journal	ORG
bptjm-32	117	2	113	CARDINAL
bptjm-32	117	3	1	CARDINAL
bptjm-32	117	4	arck	ORG
bptjm-32	117	5	paus r. neuroimmunology	PERSON
bptjm-32	119	1	2006;126(8):1697-1704	CARDINAL
bptjm-32	120	1	2	CARDINAL
bptjm-32	120	2	arck p	ORG
bptjm-32	120	3	paus r.	PERSON
bptjm-32	121	1	2006;13(5-6):347	CARDINAL
bptjm-32	122	1	3	CARDINAL
bptjm-32	122	2	weiglein	GPE
bptjm-32	122	3	albrecht a.	PERSON
bptjm-32	124	1	j mol sci	PERSON
bptjm-32	125	1	2022;23(13):7484	CARDINAL
bptjm-32	125	2	2022	CARDINAL
bptjm-32	125	3	jul 5	DATE
bptjm-32	126	1	ijms23137484 4	ORG
bptjm-32	127	1	mueller sm	PERSON
bptjm-32	127	2	hogg s	PERSON
bptjm-32	127	3	mueller jm	PERSON
bptjm-32	129	1	2017;26(10):845-853	CARDINAL
bptjm-32	130	1	doi:10.1111	ORG
bptjm-32	130	2	wheelock md	PERSON
bptjm-32	130	3	harnett ng	PERSON
bptjm-32	132	1	behav neurosci	PERSON
bptjm-32	133	1	2018;132(6):561-572	CARDINAL
bptjm-32	133	2	6	CARDINAL
bptjm-32	134	1	smith sm	PERSON
bptjm-32	134	2	dworkin rh	PERSON
bptjm-32	134	3	turk dc	GPE
bptjm-32	137	1	2017;18(7):757-777	PRODUCT
bptjm-32	141	1	2019;18(1):91-98	DATE
bptjm-32	143	1	peters	PERSON
bptjm-32	145	1	2012;4(3):271-279	CARDINAL
bptjm-32	148	1	joachim ra	PERSON
bptjm-32	148	2	kuhlmei	PERSON
bptjm-32	150	1	berl	ORG
bptjm-32	151	1	2007;85(12):1369-1378	CARDINAL
bptjm-32	153	1	slominski	PERSON
bptjm-32	153	2	paus r	PERSON
bptjm-32	153	3	elias pm	PERSON
bptjm-32	153	4	tobin	PERSON
bptjm-32	153	5	feingold kr	PERSON
bptjm-32	154	1	today	DATE
bptjm-32	155	1	2008;5(2):137-144	CARDINAL
bptjm-32	155	2	11	CARDINAL
bptjm-32	156	1	zouboulis cc	PERSON
bptjm-32	157	1	2019;177:144-149	CARDINAL
bptjm-32	158	1	doi:10.1016	GPE
bptjm-32	158	2	12	CARDINAL
bptjm-32	159	1	menezes ac	PERSON
bptjm-32	159	2	ribeiro h	PERSON
bptjm-32	159	3	oliveira h	GPE
bptjm-32	159	4	ascenso a.	PERSON
bptjm-32	159	5	5	CARDINAL
bptjm-32	159	6	5-ht2a	CARDINAL
bptjm-32	161	1	2016;53(2):1145-1164	CARDINAL
bptjm-32	163	1	slominski	PERSON
bptjm-32	163	2	zmijewski ma	PERSON
bptjm-32	163	3	szaflarski jp	PERSON
bptjm-32	163	4	paus r.	PERSON
bptjm-32	165	1	2018;159(5):1992-2007	DATE
bptjm-32	166	1	doi:10.1210	PERSON
bptjm-32	167	1	tretter yp	PERSON
bptjm-32	167	2	engelhardt f	PERSON
bptjm-32	167	3	werner s.	PERSON
bptjm-32	169	1	2001;180(1-2):169-177	CARDINAL
bptjm-32	171	1	martins am	PERSON
bptjm-32	171	2	ribeiro hm	PERSON
bptjm-32	171	3	marto j.	PERSON
bptjm-32	173	1	2020;9(4):796	CARDINAL
bptjm-32	174	1	2020	DATE
bptjm-32	174	2	mar 26	DATE
bptjm-32	175	1	berkeley pharma tech journal	ORG
bptjm-32	175	2	114 16	CARDINAL
bptjm-32	176	1	garcía-martín ab	ORG
bptjm-32	176	2	zwicky p	ORG
bptjm-32	176	3	gruber t	PERSON
bptjm-32	178	1	2019;39(10):1995-2010	DATE
bptjm-32	179	1	17	CARDINAL
bptjm-32	180	1	van opijnen mp	PERSON
bptjm-32	180	2	dirven l	PERSON
bptjm-32	180	3	taphoorn mjb	PERSON
bptjm-32	180	4	kapiteijn	PERSON
bptjm-32	184	1	18	CARDINAL
bptjm-32	185	1	schackert g	PERSON
bptjm-32	185	2	zhang rd	PERSON
bptjm-32	185	3	radinsky r	PERSON
bptjm-32	186	1	1999;18(3):387-400	CARDINAL
bptjm-32	187	1	doi:10.1023	GPE
bptjm-32	188	1	dean dn	PERSON
bptjm-32	188	2	lee jc	PERSON
bptjm-32	189	1	pmel17	ORG
bptjm-32	190	1	mov disord	PERSON
bptjm-32	191	1	2021;36(7):14891498	CARDINAL
bptjm-32	193	1	marek-jozefowicz l	ORG
bptjm-32	193	2	borkowska	ORG
bptjm-32	195	1	j mol sci	PERSON
bptjm-32	196	1	2022;23(2):669	CARDINAL
bptjm-32	197	1	2022	CARDINAL
bptjm-32	197	2	jan 8	DATE
bptjm-32	198	1	ijms23020669 21	WORK_OF_ART
bptjm-32	199	1	luo t	PERSON
bptjm-32	199	2	ma y	PERSON
bptjm-32	199	3	wei w. murine	PERSON
bptjm-32	200	1	j pharmacol toxicol	PERSON
bptjm-32	201	1	2020;101:106657	CARDINAL
bptjm-32	202	1	doi:10.1016	GPE
bptjm-32	202	2	22	CARDINAL
bptjm-32	203	1	pavlovic s	PERSON
bptjm-32	206	1	2008;128(2):434	CARDINAL
bptjm-32	207	1	doi:10.1038	ORG
bptjm-32	208	1	tretter yp	PERSON
bptjm-32	208	2	engelhardt f	PERSON
bptjm-32	208	3	werner s.	PERSON
bptjm-32	210	1	2001;180(1-2):169-177	CARDINAL
bptjm-32	212	1	nordlind k	PERSON
bptjm-32	212	2	ec	ORG
bptjm-32	212	3	slominski a.	PERSON
bptjm-32	214	1	2008;17(4):301	CARDINAL
bptjm-32	215	1	doi:10.1111/j.1600-0625.2007.00670.x	ORG
bptjm-32	216	1	2	CARDINAL